VTYX- Ventyx Biosciences, Inc.

Name: Ventyx Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ventyx Biosciences, Inc. (VTYX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. VTYX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Mohan Raju	2.37M	$18.32M	-
Other	Nuss John	489.5K	$3.78M	-
Dir	Gujrathi Sheila	40.0K	-	-
Dir	Cadoret-Manier Onaiza	40.0K	-	-
Dir	Hulme Allison	40.0K	-	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 2, 2024	Auster Martin85	Chief Financial Officer	Sell	1,405	$5.40	$7,591.92	-5.5%	-56.9%	-79.8%
Dec 20, 2023	Krueger Christopher W82	Chief Business Officer	Sell	5,293	$2.12	$11,210.04	-1.8%	+279.8%	+9.6%
Dec 20, 2023	Mohan Raju83	CEO And President	Sell	58,860	$2.12	$124,659.59	-3.6%	+279.8%	+9.6%
Dec 20, 2023	Nuss John79	Chief Scientific Officer	Sell	17,628	$2.12	$37,334.34	-6.3%	+279.8%	+9.6%
Oct 9, 2023	Nsv Partners III LP89	10% Owner	Sell	49,152	$30.03	$1,475,857.61	-0.6%	-91.3%	-93.2%
Oct 9, 2023	Subramaniam Somu89	Director, 10% Owner	Sell	49,152	$30.03	$1,475,857.61	-0.6%	-91.3%	-93.2%
Oct 5, 2023	Mohan Raju83	Chief Executive Officer	Sale+OE	30,000	$29.11	$873,231.00	-1.9%	-91.5%	-92.9%
Oct 3, 2023	Krueger Christopher W82	Chief Business Officer	Sale+OE	15,000	$29.98	$449,698.70	-2.6%	-91.8%	-93.0%
Oct 3, 2023	Nuss John79	Chief Scientific Officer	Sale+OE	10,000	$29.99	$299,932.86	-2.0%	-91.8%	-93.0%
Sep 18, 2023	Subramaniam Somu89	Director, 10% Owner	Sell	56,665	$37.81	$2,142,633.98	-0.7%	-94.3%	-93.9%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC